**Core Concept**
Gestational trophoblastic disease (GTD) encompasses a spectrum of abnormal trophoblastic proliferation and invasion, ranging from benign hydatidiform moles to malignant gestational trophoblastic neoplasia. The condition arises from the placental tissue and is often associated with abnormal pregnancy outcomes.

**Why the Correct Answer is Right**
The highest incidence of GTD is observed in countries with limited access to prenatal care, poor maternal nutrition, and high rates of malaria. These factors contribute to an increased risk of molar pregnancies, which are a common precursor to GTD. In the United States, the incidence of GTD is significantly higher in African American women compared to Caucasian women, likely due to disparities in access to healthcare. The exact pathogenesis of GTD involves abnormal trophoblastic proliferation and invasion, which may be triggered by genetic mutations or environmental factors.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify the demographic or geographic characteristics associated with the highest incidence of GTD.
**Option B:** This option is incorrect because it does not accurately reflect the global epidemiology of GTD.
**Option C:** This option is incorrect because it does not provide a clear or specific answer regarding the highest incidence of GTD.

**Clinical Pearl / High-Yield Fact**
The development of GTD is often associated with abnormal trophoblastic proliferation and invasion, which can be triggered by genetic mutations or environmental factors. Early recognition and treatment of GTD are critical to prevent complications such as persistent gestational trophoblastic neoplasia and metastatic disease.

**Correct Answer: D.**